PharmaTalkRadio

Join guests Kerri Weingard, ANP, COO, Verified Clinical Trials and Susan Salgado, PhD, Founder, Hospitality Quotient as they identify the barriers and limitations in engaging patients in clinical trials. What we can do about it through communication and service? Hosted by Valerie Bowling, Executive Director, the Conference Forum, this episode addresses one of the hottest topics at the Patients as Partners event scheduled for March 3-4, 2014 in Philadelphia. For more information, visit www.theconferenceforum.org

About our Guests:

Susan Reilly Salgado, PhD founded Hospitality Quotient with Danny Meyer in 2010.  Hospitality Quotient offers customized advice and training to inspire, build and sustain a company culture of service in organizations across industries.  In addition to her PhD, Susan holds a BS and an MBA from Lehigh University. Susan has also served as an instructor in organizational behavior and business strategy at NYU and as a guest lecturer at Lehigh.

Kerri Weingard is the chief operating officer at Verified Clinical Trials (VCT), a New York-based firm specializing in ensuring the integrity of medical studies and clinical trials by creating a database of research study participants trials. Ms. Weingard, who is a nurse practitioner, holds a master’s degree in science from Stony Brook University. She has conducted over 500 clinical trials as a research coordinator and sub-investigator.

This episode provides a recap on what's happening with mobile/sensors in clinical trials especially as they affect patients.

Host:

Craig Lipset, Head of Clinical Innovation, R&D, Pfizer, Inc. 

Guests:

Tim Davis, CEO & Co-Founder, Exco InTouch

Abbe Steel, Vice President of Patient & Physician Services, UBC

Eli Lilly and Quintiles entered into a co-investment partnership to develop a new solution using computer-assisted designs that emphasize the improvement of scientific and operational outcomes of clinical trials. The results were shared at the DPharm 2013 event and project leaders from both companies will talk to our host Craig Lipset on how this formation is doing a year later. Also joining Craig is Jeff Lee, CEO, Omniscience to discuss featured news and trends in clinical trial innovation and in particular mobile applications.

Host:

Craig Lipset, MBA, Head of Clinical Innovation, R&D, Pfizer, Inc.

Guests:

Jeffrey Kasher, PhD, VP & COO, Eli Lilly & Company

Jeff Lee, CEO, Omniscience Mobile

Rick Sax, MD, SVP Clinical Design & Reporting Services, Quintiles

A panel of executives from leading pharma and the venture capital community at the DPharm Disruptive Innovations conference recently awarded the 2013 Disruptive Innovator of the Year title to Medidata Solutions and Spaulding Clinical Research. They won for their collaboration on a novel study evaluating the impact of mobile and cloud-based technology on patient engagement for improved health outcomes in the diabetes community.

Host Craig Lipset, Head of Clinical Innovation, R&D at Pfizer speaks with Dr. Andrew Lee of Sanofi on key takeaways from the 2013 DPharm conference along with the CEOs of  the winning companies to learn more about their collaboration.

Guests:

Andrew Lee, MD, SVP, Deputy Head of Clinical Sciences & Operations, Sanofi

Glen De Vries, President of Medidata Solutions

Randy Spaulding, Founder and CEO of Spaulding Clinical Research

Join us in a discussion on serving patients in clinical trials.

Making clinical trials more accessible for patients Emerging technologies / iPads and informed consent Disruption Headlines in the news

Host:

Craig Lipset, MBA

Head of Clinical Innovation, R&D, Pfizer Inc.

Guests:

Andreas Koester, MD, PhD

VP, Clinical Trial Innovation & External Alliances,  Janssen

Anthony Costello, CEO, Mytrus

The CMO of a biotech is like no other job in the world. The CMO is not only responsible for delivering on clinical trials, but also is a key player in the company's fundraising efforts.  

From the Chief Medical Officer Summit, please join co-chairs Dr. Greg Fiore, CMO of the The Medicines Company and Dr. Steven Zelenkofske, CMO of Regado together with opening presenter Dr. Tyler Martin, CMO & Founder of Great Plains Biotechnology, to discuss the role of the CMO and how to best manage it. 

Topics include: 

What should a CMO be focused on? Functioning with restrictive capital Supporting a CEO who does not have experience in the therapeutic area you are in charge of The great balancing act

Drs. Christopher Gallen, CEO at SK BioPharmaceuticals and Mitchell Katz, Executive Director, Medical Research Operations at Purdue Pharma, in a candid conversation on navigating the complexities of Global Clinical Trials and addressing topics including:

Why global trials? Why are global trials so expensive? How are companies re-thinking global trials? What's happening with global outsourcing? Thoughts on emerging markets and patient recruitment What can we do to help mitigate the risks of global trials?

Join host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer with guests Joe Kim, Clinical Operations Director, Shire and Dr. Hugo Stevenson, physician and serial entrepreneur, as they discuss innovation transforming the clinical trial space to include:

  *   Mobile technology and apps

  *   Clinical trials and diversity

  *   Google Glass for health

  *   Investigator database sharing

  *   Key motivations for innovators and more

The opinions shared by Craig and our guests are those of the speakers and do not necessarily reflect the opinions of their employers.